FDA Brushes Up On Committee Transparency
The Food and Drug Administration released new policy guidelines for its advisory committees Thursday on the heels of concerns about potential conflicts of interest posed by members' ties to the industries...To view the full article, register now.
Already a subscriber? Click here to view full article